Shah Gaurav 4

What Happened

• Gaurav Shah, CEO of Rocket Pharmaceuticals (RCKT), sold 12,279 shares on 2026-02-13 at $3.31 per share, generating proceeds of $40,668. The sale was executed to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs), not a purchase or speculative trade.

Key Details

• Transaction date and price: 2026-02-13 — 12,279 shares sold at $3.31 each.
• Total proceeds: $40,668.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: (F1) Holdings include RSUs that convert one-for-one to common stock. (F2) The shares were sold to pay tax withholding on RSU vesting.
• Filing: Reported on 2026-02-18; timing appears to comply with Form 4 rules (filed within two business days following the transaction date).

Context

• Sales to cover tax withholding on vested RSUs are routine and generally reflect tax-management activity rather than a CEO signaling a view on the company's stock price. For retail investors, outright purchases or open-market buys tend to be more informative about insider confidence than routine withholding sales.